Skip to main content

2 Result(s)

within A Demols Remove this filter English Remove this filter

and

  1. Article

    Open Access

    Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

    Gemcitabine and oxaliplatin (GEMOX) are active as first-line therapy against advanced pancreatic cancer. This study aims to evaluate the activity and tolerability of this combination in patients refractory to ...

    A Demols, M Peeters, M Polus, R Marechal, F Gay, E Monsaert… in British Journal of Cancer (2006)

    Download PDF (103 KB) View Article

  2. No Access

    Article

    Letter to the editor

    A. Demols, A. Van Gossum, P. Clevenberg, J. P. Thys… in Digestive Diseases and Sciences (1996)